SMYD2 and gastric cancer: In addition, SMYD2 is also overexpressed in gastric cancer [66], pancreatic ductal adenocarcinoma (PDAC) [43], papillary thyroid carcinoma [80], hepatocellular carcinoma [81], and colon cancer [82].